Bosulif 400 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV321
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,904
Award facts
- Contract value 100% obligated
- $24,903.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,903.72 to AmerSourceBergen Drug Corp for the supply of Bosulif (bositinib) 400 mg tablets in a quantity of 30 units. Issued on January 7, 2026, with an ultimate completion date of January 29, 2026, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. The award falls under AmerSourceBergen's parent company, Cencora, Inc., which holds a significant indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare systems globally.
Bosulif is a targeted oncology medication used in cancer treatment, reflecting the breadth of specialized pharmaceutical products that AmerSourceBergen supplies to support military treatment facilities and federal healthcare programs. The delivery order will be fulfilled at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerSourceBergen maintains a robust federal contracting presence with the Defense Logistics Agency and consistently demonstrates capability to meet government procurement requirements for brand-name medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FV321?
SPE2DR26FV321 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FV321 worth?
The government has obligated $24,904 on SPE2DR26FV321.
Is contract SPE2DR26FV321 an order under another contract?
Yes. SPE2DR26FV321 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV321 competed?
The extent of competition for SPE2DR26FV321 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award